Facebook Linkedin Twitter
Inside Precision Medicine Geneoscopy’s RNA-Based Colorectal Cancer Test Approved by FDA

LabCorp

Image of gut and intestines showing colorectal cancer highlighted in red.
Molecular Dx

Geneoscopy’s RNA-Based Colorectal Cancer Test Approved by FDA

0
The American Clinical Laboratory Association has sued to block proposed 2018 Medicare payment rates for clinical tests calculated under the Protecting Access to Medicare Act (PAMA). [Source: Clinical Center
Molecular Dx

Clinical Lab Group Sues HHS Over Proposed PAMA 2018 Medicare Rates

Alex Philippidis
0
Proposed 2018 Medicare payment rates for clinical diagnostics
Molecular Dx

Laboratories Take Aim at Proposed PAMA 2018 Medicare Rates for Tests

Alex Philippidis
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine